National Uruguayan Experience with PSMA PET/CT in Initial Staging in High-risk prostate cancer

G dos Santos, A Banchero, A Quagliata, N Niell… - 2024 - Soc Nuclear Med
241286 Introduction: Prostate-specific membrane antigen positron emission tomography
(PSMA PET/CT) is an emerging imaging modality for the evaluation of prostate cancer …
相关文章

Comparative analysis of contemporary and past PSMA PET/CT results for recurrent prostate cancer in a high-volume Brazilian center.

DPS Lages, L Monteiro do Prado Junior… - 2023 - ascopubs.org
51 Background: PSMA PET/CT scan (68Ga-PSMA PET/CT) has emerged as a highly
accurate tool when assessing disease staging both for newly diagnosed localized high-risk …
相关文章

Performance of the F-PSMA 1007 PET/CT for high-risk prostate cancer staging: Experience from a Latin American reference center.

S Peña Rodriguez, CA Diaz Ritter, JI Caicedo… - 2024 - ascopubs.org
286 Background: Diagnostic staging in high-risk prostate cancer patients seeks to define the
local extent of the disease as well as determine the presence of lymph nodes and distant …
相关文章
[PDF] vu.nl

[PDF][PDF] PSMA PET/CT IMAGING IN THE EARLY DETECTION OF CANCER OF THE PROSTATE WITH HIGH RISK FEATURES. THE PEACH TRIAL

YJL Bodar, LMS Boevé, PJ van Leeuwen… - VU Research …, 2023 - research.vu.nl
Background Prostate-specific membrane antigen (PSMA) positron-emission tomography
(PET)/CT has been successfully introduced for the staging of patients with prostate cancer …
相关文章
[PDF] redjournal.org

Impact of 68Ga-PSMA-11 PET/CT on initial staging of high-risk prostate cancer patients: Post-hoc analysis of a prospective single center experience

TM Ma, D Shabsovich, JE Juarez, P Thin… - International Journal of …, 2020 - redjournal.org
Results Overall, 22.9% patients were upstaged by PSMA PET; 18.9% of patients with iN0
disease by CT or MRI were found to have N1 disease by PSMA PET, and 10.6% of patients …
被引用次数：1 相关文章
[PDF] kuleuven.be

PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management

P Claes, N Ahmadi Bidakhvidi, A Giesen… - Clinical and …, 2024 - Springer
Purpose In the last decade, prostate specific membrane antigen (PSMA) positron emission
tomography (PET) has gained its role as a novel tool in the primary staging of prostate …
相关文章 所有 3 个版本

PSMA PET/CT and staging high risk prostate cancer: a non-systematic review of high clinical impact literature.

JJ Morigi, J Anderson, C De Nunzio, S Fanti - 2020 - digitallibrary.health.nt.gov.au
INTRODUCTION: Prostate specific membrane antigen (PSMA) positron emission
tomography (PET) with computed tomography (CT) is a promising molecular imaging …
被引用次数：3 相关文章
[PDF] springer.com

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial

A Holzgreve, M Unterrainer, J Calais, T Adams… - European journal of …, 2023 - Springer
Purpose The proPSMA trial at ten Australian centers demonstrated increased sensitivity and
specificity for PSMA PET/CT compared to conventional imaging regarding metastatic status …
被引用次数：9 相关文章 所有 10 个版本
[PDF] springer.com

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial

C Ménard, S Young, K Zukotynski, RJ Hamilton… - BMC cancer, 2022 - Springer
Background Positron emission tomography targeting the prostate specific membrane
antigen (PSMA PET/CT) has demonstrated unparalleled performance as a staging …
被引用次数：13 相关文章 所有 14 个版本

Updated experience on PSMA PET/CT for recurrent prostate cancer in a high-volume Brazilian center.

DPS Lages, L Monteiro do Prado Junior… - 2023 - ascopubs.org
50 Background: PSMA PET/CT scan (68Ga-PSMA PET/CT) has emerged as a highly
accurate tool when assessing disease staging both for newly diagnosed localized high-risk …
相关文章